688358.SS · 祥生医疗
China A-shares · RS rating 50 · As of 2026-10-14
| Price | 27.00 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 57 / 24 / 59 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 24 / 9 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -10.3% |
| Distance from 52-week high | +35.6% |
| Market cap (USD) | $466.0M |